Gwendolyn Binder - 18 Jan 2023 Form 4 Insider Report for Cabaletta Bio, Inc. (CABA)

Role
President, Science & Technology
Signature
By: /s/ Michael Gerard, as Attorney-in-Fact
Issuer symbol
CABA
Transactions as of
18 Jan 2023
Net transactions value
$0
Form type
4
Filing time
27 Jan 2023, 19:50:23 UTC
Previous filing
18 Oct 2022
Next filing
19 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CABA Stock Option (Right to Buy) Award $0 +176,000 $0.000000 176,000 18 Jan 2023 Common Stock 176,000 $11.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option shall vest and become exercisable on January 18, 2024, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date.

Remarks:

President, Science & Technology